C.R. Bard, Inc. Market Share Analysis

GlobalData, October 2010, Pages: 166

C.R. Bard, Inc. Market Share Analysis

Summary

Our new report, “C.R. Bard, Inc. Market Share Analysis” provides in-depth information on C.R. Bard’s market position in the different medical equipment markets it operates in. The report provides C.R. Bard’s market share information in three key market categories – Peripheral Vascular Devices, Electrophysiology and Incontinence Devices. The report also provides data and information on the overall competitive landscape of the markets, the company operates in. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.

Scope

- Global company shares (in Revenues) information for the key markets C.R. Bard operates in – Nephrology and Urology Devices and Cardiovascular Devices.
- C.R. Bard’s company shares (in Revenues) information for all the key countries the company has presence in – United States, Canada, UK, Germany, France, Italy, Spain, Japan, China, India, and Australia.
- C.R. Bard’s company shares (in Revenues) information for all the key market categories the company has presence in – Peripheral Vascular Devices, Electrophysiology and Incontinence Devices.
- All the key data-points are for 2009 and cover all the key regions – North America, Europe, Asia Pacific (APAC), and Middle East and Africa (MEA).
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries, if any – Mergers & Acquisitions (M&A), Asset Transactions, PE/VC, Equity Offerings, Debt Offerings, and Partnerships.

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, C.R. Bard operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to C.R. Bard’s market positions.

1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of Markets/Categories Covered
3.1 Nephrology and Urology Devices
3.1.1 Incontinence Devices
3.1.2 Lithotripters
3.1.3 Renal Dialysis Equipment
3.2 Cardiovascular Devices
3.2.1 Cardiac Assist Devices
3.2.2 Cardiac Rhythm Management
3.2.3 Cardiovascular Monitoring and Diagnostic Devices
3.2.4 Cardiovascular Prosthetic Devices
3.2.5 Cardiovascular Surgery
3.2.6 Electrophysiology
3.2.7 External Defibrillator
3.2.8 Interventional Cardiology
3.2.9 Peripheral Vascular Devices
3.2.10 Prosthetic Heart Valve
4 Company Snapshot
4.1 Key Information
4.2 Company Overview
4.3 Financial Performance
4.4 SWOT Snapshot
5 Business Description
5.1 Business Overview
5.2 Oncology Product Line
5.2.1 Overview
5.2.2 Financials
5.2.3 Key Strategies
5.3 Other Products Product Line
5.3.1 Overview
5.3.2 Financials
5.4 Surgical Specialties Product Line
5.4.1 Overview
5.4.2 Financials
5.4.3 Key Strategies
5.5 Urology Product Line
5.5.1 Overview
5.5.2 Financials
5.6 Vascular Product Line
5.6.1 Overview
5.6.2 Financials
5.6.3 Market View
5.7 Major Products and Services
5.7.1 Overview
6 History
7 SWOT Analysis
7.1 Overview
7.2 C. R. Bard, Inc. Strengths
7.2.1 Product Development
7.2.2 Diversified Operations
7.2.3 Expanding Operating Margin
7.2.4 Strong Liquidity Position
7.2.5 Efficient Use of Resources
7.3 C. R. Bard, Inc. Weaknesses
7.3.1 Limited Investor Confidence
7.3.2 Legal Proceedings
7.3.3 Voluntary Product Recalls
7.3.4 Dependence on the US Market
7.4 C. R. Bard, Inc. Opportunities
7.4.1 Inorganic Growth Strategy
7.4.2 Emerging Markets
7.4.3 Product Approvals and Strong Pipeline
7.4.4 Growing Aged Population
7.5 C. R. Bard, Inc. Threats
7.5.1 Competitive Landscape
7.5.2 Healthcare Reform Bill
7.5.3 Rapid Technological Changes
7.5.4 Cost Containment Pressures
7.5.5 Rising Counterfeit Market
8 Competitors
9 Competitive Landscape
9.1 Nephrology and Urology Devices, Global, Company Share (%), 2009
9.2 Cardiovascular Devices, Global, Company Share (%), 2009
10 C. R. Bard, Inc. Medical Equipment Market Share Analysis
10.1 C. R. Bard, Inc., Global, Market Share (2009)
10.2 C. R. Bard, Inc., Asia-Pacific, Market Share (2009)
10.2.1 C. R. Bard, Inc., Australia, Market Share (2009)
10.2.2 C. R. Bard, Inc., China, Market Share (2009)
10.2.3 C. R. Bard, Inc., India, Market Share (2009)
10.2.4 C. R. Bard, Inc., Japan, Market Share (2009)
10.2.5 C. R. Bard, Inc., Other Asia-Pacific, Market Share (2009)
10.3 C. R. Bard, Inc., Europe, Market Share (2009)
10.3.1 C. R. Bard, Inc., France, Market Share (2009)
10.3.2 C. R. Bard, Inc., Germany, Market Share (2009)
10.3.3 C. R. Bard, Inc., Italy, Market Share (2009)
10.3.4 C. R. Bard, Inc., Spain, Market Share (2009)
10.3.5 C. R. Bard, Inc., United Kingdom, Market Share (2009)
10.3.6 C. R. Bard, Inc., Other Europe, Market Share (2009)
10.4 C. R. Bard, Inc., Middle East and Africa, Market Share (2009)
10.5 C. R. Bard, Inc., North America, Market Share (2009)
10.5.1 C. R. Bard, Inc., Canada, Market Share (2009)
10.5.2 C. R. Bard, Inc., United States, Market Share (2009)
10.6 C. R. Bard, Inc., South and Central America, Market Share (2009)
10.6.1 C. R. Bard, Inc., Brazil, Market Share (2009)
10.6.2 C. R. Bard, Inc., Other South and Central America, Market Share (2009)
11 C. R. Bard, Inc. Medical Equipment Market Share Analysis by Category
11.1 C. R. Bard, Inc., Global, Category Revenue Share (2009)
11.2 C. R. Bard, Inc., Asia-Pacific, Category Revenue Share (2009)
11.2.1 C. R. Bard, Inc., Australia, Category Revenue Share (2009)
11.2.2 C. R. Bard, Inc., China, Category Revenue Share (2009)
11.2.3 C. R. Bard, Inc., India, Category Revenue Share (2009)
11.2.4 C. R. Bard, Inc., Japan, Category Revenue Share (2009)
11.2.5 C. R. Bard, Inc., Other Asia-Pacific, Category Revenue Share (2009)
11.3 C. R. Bard, Inc., Europe, Category Revenue Share (2009)
11.3.1 C. R. Bard, Inc., France, Category Revenue Share (2009)
11.3.2 C. R. Bard, Inc., Germany, Category Revenue Share (2009)
11.3.3 C. R. Bard, Inc., Italy, Category Revenue Share (2009)
11.3.4 C. R. Bard, Inc., Spain, Category Revenue Share (2009)
11.3.5 C. R. Bard, Inc., United Kingdom, Category Revenue Share (2009)
11.3.6 C. R. Bard, Inc., Other Europe, Category Revenue Share (2009)
11.4 C. R. Bard, Inc., Middle East and Africa, Category Revenue Share (2009)
11.5 C. R. Bard, Inc., North America, Category Revenue Share (2009)
11.5.1 C. R. Bard, Inc., Canada, Category Revenue Share (2009)
11.5.2 C. R. Bard, Inc., United States, Category Revenue Share (2009)
11.6 C. R. Bard, Inc., South and Central America, Category Revenue Share (2009)
11.6.1 C. R. Bard, Inc., Brazil, Category Revenue Share (2009)
11.6.2 C. R. Bard, Inc., Other South and Central America, Category Revenue Share (2009)
12 Key Employees
13 Key Employee Biographies
14 Company Statement
15 Locations And Subsidiaries
15.1 Head Office
15.2 Other Locations & Subsidiaries
16 Financial Deals Landscape
16.1 C. R. Bard, Inc., Deals Volume Summary, 2005 to YTD 2010
17 C. R. Bard, Inc., Deals Summary By Region, 2005 to YTD 2010
18 C. R. Bard, Inc. Detailed Deal Summary
18.1 Asset Purchase
18.1.1 PacerView Technologies Sells PacerView Technology To Bard Access Systems
18.1.2 Spire Completes Sale Of Hemodialysis Catheter Business To Bard Access Systems
18.1.3 Davol Acquires XenMatrix From Brennen Medical
18.1.4 Edwards Lifesciences Sells LifeStent Product Line Assets To C. R. Bard
18.1.5 C. R. Bard Acquires Assets From Inrad
18.1.6 C. R. Bard Acquires EasyTac From Agency for Medical Innovations
18.1.7 C. R. Bard Acquires Stent Technology Assets From PST
18.1.8 C. R. Bard Acquires Assets From Genyx Medical
18.1.9 C. R. Bard Acquires Assets From Sorenson Medical
18.1.10 C. R. Bard Acquires Assets From Advanced Surgical
18.2 Partnerships
18.2.1 Medegen Signs An Agreement With C. R. Bard
18.2.2 Tutogen Medical Enters Into Distribution Agreement With Davol
18.2.3 CardioTech International Enters Into An Agreement With Bard Access Systems
18.2.4 Covalon Technologies Signs Licensing Agreement With C. R. Bard
18.2.5 C. R. Bard Signs Licensing Agreement With Genzyme
18.2.6 TyRx Pharma Enters Into Licensing Agreement With C. R. Bard
18.3 Divestiture - Assets
18.3.1 CONMED Acquires Endoscopic Technologies Product Line From C. R. Bard
18.4 Acquisition
18.4.1 C. R. Bard Completes Acquisition Of SenoRx
18.4.2 C. R. Bard Completes Acquisition Of FlowCardia
18.4.3 C. R. Bard Acquires Y-Med
18.4.4 C. R. Bard Acquires Specialized Health Products International
18.4.5 Specialized Health Products Acquires The Med-Design
18.4.6 C. R. Bard Acquires Venetec International
18.4.7 C. R. Bard Acquires Onux Medical
18.4.8 C. R. Bard Acquires Bridger Biomed
19 Appendix
19.1 Research Methodology
19.2 Secondary Research
19.3 Primary Research
19.4 Models
19.5 Forecasts
19.6 Expert Panels
19.7 Consulting
19.8 Currency Conversion
19.9 Contact Us
19.10 Disclaimer

Abbott Laboratories
American Medical Systems Holdings, Inc.
Asahi Kasei Corporation
B. Braun Melsungen AG
Baxter International Inc.
Biosense Webster, Inc.
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
Coloplast A/S
Cordis Corporation
Covidien plc
Edwards Lifesciences Corporation
Fresenius Medical Care AG & Co. KGaA
Gambro AB
Hartmann Group
Kimberly-Clark Corporation
Medtronic, Inc.
NIPRO CORPORATION
Ontex N.V.
Philips Healthcare
Sorin Group
St. Jude Medical, Inc.
STERIS Corporation
Svenska Celulosa Aktiebolaget SCA
Teleflex Incorporated
Terumo Corporation
Tyco Healthcare/Kendall
Unicharm Corporation

Customers who bought this item also bought

• Charter Schools - Global Outlook
• eLEARNING - Global Strategic Business Report
• Aerospace and Defense Industry - Global Strategic Business Report
• North America – Smart Weapons Markets and Technologies Outlook – 2013-2020
• Sports and Fitness Nutrition - Global Strategic Business Report
• Education Services - Global Strategic Business Report
• Commercial And Military Flight Simulation - Global Strategic Business Report
• The Worldwide Industry & Market Opportunities and forecasts to 2014 for Microwaves Global Military & Space-Related Systems
• The Global UAV Payload Market 2012-2022
• Private Tutoring - Global Strategic Business Report